Remi Barbier
Chief Executive Officer bei CASSAVA SCIENCES, INC.
Vermögen: 27 Mio $ am 31.03.2024
Profil
Remi Barbier is the founder of Cassava Sciences, Inc. which was founded in 1998.
He held the titles of Chairman, President & Chief Executive Officer.
Mr. Barbier's current jobs include Director positions at Santa Fe Institute of Science, Poetic Genetics, Inc., and Bioventures LLC.
Mr. Barbier's former jobs include Vice President-Corporate Development at XOMA Corp.
from 1993 to 1995 and Chief Operating Officer at Exelixis, Inc. from 1996 to 1998.
He is also a Trustee-Emeritus at Carnegie Institution of Washington.
Mr. Barbier's education includes an undergraduate degree from Oberlin College and an MBA from The University of Chicago.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CASSAVA SCIENCES, INC.
3,10% | 19.03.2024 | 1 338 157 ( 3,10% ) | 27 Mio $ | 31.03.2024 |
Aktive Positionen von Remi Barbier
| Unternehmen | Position | Beginn |
|---|---|---|
| CASSAVA SCIENCES, INC. | Chief Executive Officer | 01.05.1998 |
| Poetic Genetics, Inc. | Director/Board Member | - |
Santa Fe Institute of Science
 Santa Fe Institute of Science Miscellaneous Commercial ServicesCommercial Services Santa Fe Institute of Science operates as a nonprofit, independent research center. It provides research and education services. The company was founded by George Cowan, David Pines, Stirling Colgate, Murray Gell-Mann, Nick Metropolis, Herb Anderson, Peter A. Carruthers, and Richard Slansky in May 1984 and is headquartered in Santa Fe, NM. | Director/Board Member | - |
Bioventures LLC
 Bioventures LLC Pharmaceuticals: MajorHealth Technology Bioventures LLC is a pharmaceutical company that develops pharmaceutical products. The private company is based in Tulsa, OK and was founded in 2004. | Director/Board Member | - |
Ehemalige bekannte Positionen von Remi Barbier
| Unternehmen | Position | Ende |
|---|---|---|
| EXELIXIS, INC. | Chief Operating Officer | 01.05.1998 |
| XOMA CORPORATION | Corporate Officer/Principal | 01.12.1995 |
Carnegie Institution of Washington
 Carnegie Institution of Washington Miscellaneous Commercial ServicesCommercial Services Carnegie Institution of Washington is engaged in providing technical and scientific research services. The company was founded by Andrew Carnegie in 1895 and is headquartered in Washington, DC. | Director/Board Member | - |
Ausbildung von Remi Barbier
| Oberlin College | Undergraduate Degree |
| The University of Chicago | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| XOMA CORPORATION | Health Technology |
| EXELIXIS, INC. | Health Technology |
| CASSAVA SCIENCES, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Carnegie Institution of Washington
Carnegie Institution of Washington Miscellaneous Commercial ServicesCommercial Services Carnegie Institution of Washington is engaged in providing technical and scientific research services. The company was founded by Andrew Carnegie in 1895 and is headquartered in Washington, DC. | Commercial Services |
Santa Fe Institute of Science
Santa Fe Institute of Science Miscellaneous Commercial ServicesCommercial Services Santa Fe Institute of Science operates as a nonprofit, independent research center. It provides research and education services. The company was founded by George Cowan, David Pines, Stirling Colgate, Murray Gell-Mann, Nick Metropolis, Herb Anderson, Peter A. Carruthers, and Richard Slansky in May 1984 and is headquartered in Santa Fe, NM. | Commercial Services |
| Poetic Genetics, Inc. | |
Bioventures LLC
Bioventures LLC Pharmaceuticals: MajorHealth Technology Bioventures LLC is a pharmaceutical company that develops pharmaceutical products. The private company is based in Tulsa, OK and was founded in 2004. | Health Technology |
